Tirzepatide Therapy

What Is Tirzepatide?

Tirzepatide is a once-weekly injectable medication that acts on two of the body’s incretin hormone pathways at the same time. It is a dual agonist, meaning it activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual mechanism distinguishes it from medications that target GLP-1 alone.

Tirzepatide is FDA-approved under two brand names: one indicated for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve blood sugar control, and another indicated for chronic weight management in adults who have obesity or who are overweight with at least one weight-related health condition. The medication is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm.

How Tirzepatide Works

Incretin hormones are released by the gut after eating and help regulate blood sugar and appetite. By activating the GIP and GLP-1 receptors, tirzepatide influences several processes:

• Stimulates insulin release in a glucose-dependent manner, meaning it primarily acts when blood sugar is elevated, which lowers the risk of low blood sugar compared with some other diabetes medications.
• Suppresses glucagon, a hormone that raises blood sugar, when glucose levels are high.
• Slows gastric emptying, so the stomach empties more gradually and a sense of fullness lasts longer after meals.
• Acts on appetite centers in the brain to reduce hunger and food intake.

Together, these effects can improve glycemic control and support meaningful, gradual weight loss when paired with nutrition and activity changes.

What to Expect During Treatment

Tirzepatide is started at a low dose and increased in steps over time. This gradual titration is standard practice and helps the body adjust while reducing the chance and severity of side effects. Dose increases are guided by how well the medication is tolerated and by treatment goals, and your clinician will determine the appropriate schedule for you.

Because it is dosed once weekly, many patients find it convenient to fit into a routine. Results are not immediate; appetite and blood sugar changes often appear within the first weeks, while weight and metabolic improvements typically build over several months of consistent use combined with lifestyle changes.

Common Side Effects

The most frequently reported side effects are gastrointestinal and tend to be most noticeable when starting the medication or after a dose increase. These can include:

• Nausea
• Diarrhea or constipation
• Vomiting
• Reduced appetite, abdominal discomfort, or indigestion

These effects are often mild to moderate and frequently lessen over time. Slower dose escalation, smaller meals, and dietary adjustments may help. Less common but more serious concerns can include inflammation of the pancreas (pancreatitis), gallbladder problems, and dehydration related to persistent vomiting or diarrhea. Tell your clinician promptly about severe or ongoing abdominal pain or other concerning symptoms.

Important Safety Considerations

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors based on animal studies; it is not recommended for people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2. It is not a substitute for insulin and is not indicated for type 1 diabetes. The medication has not been established as safe during pregnancy, and it may affect the absorption of oral medications, including oral contraceptives, because it slows gastric emptying. A thorough medical history and current medication review are essential before starting.

Who May Be a Candidate

Tirzepatide may be appropriate for adults seeking better blood sugar control with type 2 diabetes, or for adults pursuing chronic weight management who meet established weight and health criteria. Candidacy is individualized and depends on your medical history, current medications, lab work, and personal goals. It is intended to complement, not replace, healthy eating, physical activity, and ongoing clinical follow-up.

At ENNU Life, serving Louisville and the greater Kentucky area, tirzepatide therapy is offered as part of a supervised, comprehensive approach to metabolic and weight-management care that includes evaluation, lab assessment where appropriate, dose titration, and monitoring over time.

Monitoring and Follow-Up

Ongoing follow-up allows your clinician to track progress, adjust dosing, monitor for side effects, and review relevant labs. Blood sugar markers, weight trends, and tolerability are all part of routine assessment. Open communication about how you are feeling between visits helps your care team tailor the plan to you.

Take the Next Step

If you are curious whether tirzepatide therapy fits your health goals, a clinical evaluation is the place to start. Take our health assessment to begin the conversation with our team.

Educational only, not medical advice; consult a licensed clinician. This page does not establish a clinician-patient relationship, and individual results and candidacy vary. Always discuss your specific medical history, medications, and treatment options with a qualified healthcare provider before beginning any therapy.